Exact Sciences Corporation (EXAS)
USD 57.38
(-4.95%)
USD 57.38
(-4.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.84 Billion USD | 22.23% |
| 2022 | 1.5 Billion USD | 15.41% |
| 2021 | 1.3 Billion USD | 15.06% |
| 2020 | 1.13 Billion USD | 72.39% |
| 2019 | 659.57 Million USD | 96.02% |
| 2018 | 336.48 Million USD | 80.14% |
| 2017 | 186.79 Million USD | 244.76% |
| 2016 | 54.18 Million USD | 262.75% |
| 2015 | 14.93 Million USD | 691.06% |
| 2014 | -2.52 Million USD | -160.98% |
| 2013 | 4.14 Million USD | 0.0% |
| 2012 | 4.14 Million USD | 0.12% |
| 2011 | 4.13 Million USD | -22.2% |
| 2010 | 5.32 Million USD | 12.28% |
| 2009 | 4.73 Million USD | 645.85% |
| 2008 | -868 Thousand USD | -149.63% |
| 2007 | 1.74 Million USD | -55.62% |
| 2006 | 3.94 Million USD | 6.98% |
| 2005 | 3.68 Million USD | -17.18% |
| 2004 | 4.44 Million USD | 54.5% |
| 2003 | 2.87 Million USD | 224.21% |
| 2002 | 888 Thousand USD | 1645.63% |
| 2001 | 50.87 Thousand USD | -87.41% |
| 2000 | 404.14 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 467.42 Million USD | -1.61% |
| 2024 Q2 | 486.1 Million USD | 4.0% |
| 2024 Q3 | 512.58 Million USD | 5.44% |
| 2023 FY | 1.84 Billion USD | 22.23% |
| 2023 Q4 | 475.06 Million USD | 3.32% |
| 2023 Q1 | 445.58 Million USD | 9.79% |
| 2023 Q2 | 465.1 Million USD | 4.38% |
| 2023 Q3 | 459.81 Million USD | -1.14% |
| 2022 Q2 | 377.04 Million USD | 7.15% |
| 2022 Q4 | 405.84 Million USD | 8.17% |
| 2022 FY | 1.5 Billion USD | 15.41% |
| 2022 Q1 | 351.87 Million USD | -0.81% |
| 2022 Q3 | 375.17 Million USD | -0.5% |
| 2021 FY | 1.3 Billion USD | 15.06% |
| 2021 Q1 | 292.07 Million USD | -20.32% |
| 2021 Q2 | 320.81 Million USD | 9.84% |
| 2021 Q3 | 340.67 Million USD | 6.19% |
| 2021 Q4 | 354.75 Million USD | 4.13% |
| 2020 Q3 | 313.26 Million USD | 64.03% |
| 2020 FY | 1.13 Billion USD | 72.39% |
| 2020 Q4 | 366.57 Million USD | 17.02% |
| 2020 Q2 | 190.97 Million USD | -28.26% |
| 2020 Q1 | 266.22 Million USD | 18.24% |
| 2019 FY | 659.57 Million USD | 96.02% |
| 2019 Q4 | 225.15 Million USD | 35.63% |
| 2019 Q3 | 166 Million USD | 11.93% |
| 2019 Q1 | 118.79 Million USD | 13.33% |
| 2019 Q2 | 148.3 Million USD | 24.85% |
| 2018 Q2 | 75.99 Million USD | 12.78% |
| 2018 Q1 | 67.38 Million USD | 5.43% |
| 2018 Q3 | 88.29 Million USD | 16.18% |
| 2018 Q4 | 104.82 Million USD | 18.72% |
| 2018 FY | 336.48 Million USD | 80.14% |
| 2017 Q1 | 31.36 Million USD | 46.72% |
| 2017 FY | 186.79 Million USD | 244.76% |
| 2017 Q4 | 63.91 Million USD | 23.2% |
| 2017 Q3 | 51.87 Million USD | 30.84% |
| 2017 Q2 | 39.64 Million USD | 26.41% |
| 2016 Q2 | 11.08 Million USD | 93.29% |
| 2016 Q3 | 15.91 Million USD | 43.57% |
| 2016 Q1 | 5.73 Million USD | -15.07% |
| 2016 FY | 54.18 Million USD | 262.75% |
| 2016 Q4 | 21.37 Million USD | 34.31% |
| 2015 Q3 | 5.1 Million USD | 68.73% |
| 2015 Q4 | 6.75 Million USD | 32.31% |
| 2015 Q2 | 3.02 Million USD | 4483.33% |
| 2015 Q1 | 66 Thousand USD | 103.48% |
| 2015 FY | 14.93 Million USD | 691.06% |
| 2014 Q1 | 294 Thousand USD | -71.62% |
| 2014 FY | -2.52 Million USD | -160.98% |
| 2014 Q4 | -1.89 Million USD | -105.3% |
| 2014 Q3 | -924 Thousand USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2013 Q2 | 1.03 Million USD | 0.0% |
| 2013 Q3 | 1.03 Million USD | 0.0% |
| 2013 Q1 | 1.03 Million USD | 0.0% |
| 2013 Q4 | 1.03 Million USD | 0.0% |
| 2013 FY | 4.14 Million USD | 0.0% |
| 2012 Q3 | 1.03 Million USD | 0.0% |
| 2012 FY | 4.14 Million USD | 0.12% |
| 2012 Q2 | 1.03 Million USD | 0.0% |
| 2012 Q4 | 1.03 Million USD | 0.0% |
| 2012 Q1 | 1.03 Million USD | 0.0% |
| 2011 Q3 | 1.03 Million USD | -0.29% |
| 2011 FY | 4.13 Million USD | -22.2% |
| 2011 Q2 | 1.03 Million USD | 0.19% |
| 2011 Q1 | 1.03 Million USD | -24.47% |
| 2011 Q4 | 1.03 Million USD | 0.29% |
| 2010 Q1 | 1.29 Million USD | 4.53% |
| 2010 Q3 | 1.35 Million USD | 3.21% |
| 2010 Q4 | 1.36 Million USD | 1.41% |
| 2010 FY | 5.32 Million USD | 12.28% |
| 2010 Q2 | 1.3 Million USD | 1.16% |
| 2009 Q3 | 1.25 Million USD | 0.08% |
| 2009 FY | 4.73 Million USD | 645.85% |
| 2009 Q4 | 1.23 Million USD | -1.12% |
| 2009 Q2 | 1.25 Million USD | 25.0% |
| 2009 Q1 | 1 Million USD | 1017.43% |
| 2008 Q3 | -663 Thousand USD | 0.0% |
| 2008 Q4 | -109 Thousand USD | 83.56% |
| 2008 FY | -868 Thousand USD | -149.63% |
| 2008 Q1 | 50 Thousand USD | 108.33% |
| 2008 Q2 | - USD | -100.0% |
| 2007 Q4 | -600 Thousand USD | -995.52% |
| 2007 FY | 1.74 Million USD | -55.62% |
| 2007 Q1 | 1.16 Million USD | 1.21% |
| 2007 Q2 | 1.11 Million USD | -4.62% |
| 2007 Q3 | 67 Thousand USD | -93.99% |
| 2006 Q4 | 1.15 Million USD | 9.59% |
| 2006 FY | 3.94 Million USD | 6.98% |
| 2006 Q1 | 606 Thousand USD | -46.42% |
| 2006 Q2 | 1.12 Million USD | 86.14% |
| 2006 Q3 | 1.05 Million USD | -6.65% |
| 2005 Q4 | 1.13 Million USD | 31.05% |
| 2005 FY | 3.68 Million USD | -17.18% |
| 2005 Q3 | 863 Thousand USD | 75.76% |
| 2005 Q2 | 491 Thousand USD | -59.05% |
| 2005 Q1 | 1.19 Million USD | 8.7% |
| 2004 Q1 | 1.14 Million USD | -1.55% |
| 2004 Q2 | 1.16 Million USD | 1.48% |
| 2004 Q4 | 1.1 Million USD | 6.26% |
| 2004 Q3 | 1.03 Million USD | -10.67% |
| 2004 FY | 4.44 Million USD | 54.5% |
| 2003 Q1 | 405 Thousand USD | -0.18% |
| 2003 FY | 2.87 Million USD | 224.21% |
| 2003 Q2 | 406 Thousand USD | 0.25% |
| 2003 Q3 | 905 Thousand USD | 122.91% |
| 2003 Q4 | 1.16 Million USD | 28.51% |
| 2002 Q1 | 38.89 Thousand USD | 110.77% |
| 2002 Q4 | 405.73 Thousand USD | 0.1% |
| 2002 Q2 | 38.05 Thousand USD | -2.17% |
| 2002 FY | 888 Thousand USD | 1645.63% |
| 2002 Q3 | 405.32 Thousand USD | 965.2% |
| 2001 Q2 | 211.09 Thousand USD | 12.48% |
| 2001 Q4 | -360.99 Thousand USD | -2857.97% |
| 2001 Q1 | 187.67 Thousand USD | 0.0% |
| 2001 FY | 50.87 Thousand USD | -87.41% |
| 2001 Q3 | 13.08 Thousand USD | -93.8% |
| 2000 FY | 404.14 Thousand USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -19192.473% |
| Prenetics Global Limited | 8.82 Million USD | -20800.811% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -15374.744% |
| CareDx, Inc | 178.32 Million USD | -934.918% |
| Exagen Inc. | 29.45 Million USD | -6165.338% |
| Inotiv, Inc. | 165.44 Million USD | -1015.501% |
| Guardant Health, Inc. | 336.89 Million USD | -447.801% |
| Biodesix, Inc. | 36.07 Million USD | -5015.497% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -138713.146% |
| Precipio, Inc. | 6.01 Million USD | -30566.633% |
| iSpecimen Inc. | 5.1 Million USD | -36030.547% |
| Natera, Inc. | 492.74 Million USD | -274.542% |
| Aspira Women's Health Inc. | 5.26 Million USD | -34972.558% |
| Standard BioTools Inc. | 50.45 Million USD | -3558.113% |
| 23andMe Holding Co. | 99.37 Million USD | -1757.088% |
| Castle Biosciences, Inc. | 174.8 Million USD | -955.752% |
| Personalis, Inc. | 18.2 Million USD | -10035.754% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -13915.173% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -33252.14% |
| OpGen, Inc. | -90.69 Thousand USD | 2034984.336% |
| T2 Biosystems, Inc. | -8.17 Million USD | 22688.96% |
| Myriad Genetics, Inc. | 476.4 Million USD | -287.388% |
| ICON Public Limited Company | 1.81 Billion USD | -1.722% |
| NeoGenomics, Inc. | 244.6 Million USD | -654.492% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -15374.744% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 15.729% |
| RadNet, Inc. | 93 Million USD | -1884.428% |
| MDxHealth SA | 43.92 Million USD | -4101.138% |
| Psychemedics Corporation | 8.41 Million USD | -21836.503% |
| Illumina, Inc. | 2.74 Billion USD | 32.744% |
| Check-Cap Ltd. | -212 Thousand USD | 870627.358% |
| Twist Bioscience Corporation | 133.34 Million USD | -1283.976% |
| DarioHealth Corp. | 5.98 Million USD | -30740.876% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -1666.79% |
| Sera Prognostics, Inc. | 96 Thousand USD | -1922314.583% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 670098.657% |
| OPKO Health, Inc. | 318.12 Million USD | -480.12% |
| Medpace Holdings, Inc. | 524.5 Million USD | -251.859% |
| Neogen Corporation | 463.9 Million USD | -297.827% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -129353.167% |
| Prenetics Global Limited | 8.82 Million USD | -20800.811% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -362008.39% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -233033.278% |
| Trinity Biotech plc | 19.45 Million USD | -9388.524% |
| Neuronetics, Inc. | 51.7 Million USD | -3469.322% |
| Sotera Health Company | 577.15 Million USD | -219.76% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -233033.278% |